AT349136B - Verfahren zur herstellung einer hepatitis- virus-vakzine - Google Patents

Verfahren zur herstellung einer hepatitis- virus-vakzine

Info

Publication number
AT349136B
AT349136B AT186276A AT186276A AT349136B AT 349136 B AT349136 B AT 349136B AT 186276 A AT186276 A AT 186276A AT 186276 A AT186276 A AT 186276A AT 349136 B AT349136 B AT 349136B
Authority
AT
Austria
Prior art keywords
producing
hepatitis virus
virus vaccine
vaccine
hepatitis
Prior art date
Application number
AT186276A
Other languages
English (en)
Other versions
ATA186276A (de
Inventor
Alfred M Prince
John Vnek
Alexander Robert Neurath
Christian Trepo
Original Assignee
Community Blood Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7508046A external-priority patent/FR2303562A1/fr
Application filed by Community Blood Council filed Critical Community Blood Council
Publication of ATA186276A publication Critical patent/ATA186276A/de
Application granted granted Critical
Publication of AT349136B publication Critical patent/AT349136B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT186276A 1975-03-14 1976-03-15 Verfahren zur herstellung einer hepatitis- virus-vakzine AT349136B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7508046A FR2303562A1 (fr) 1975-03-14 1975-03-14 Nouvelle preparation d'antigene utilisable comme vaccin
US05/631,961 US4118479A (en) 1975-03-14 1975-11-17 Vaccine for active immunization containing hepatitis B surface antigen and associated antigen

Publications (2)

Publication Number Publication Date
ATA186276A ATA186276A (de) 1978-08-15
AT349136B true AT349136B (de) 1979-03-26

Family

ID=26218778

Family Applications (1)

Application Number Title Priority Date Filing Date
AT186276A AT349136B (de) 1975-03-14 1976-03-15 Verfahren zur herstellung einer hepatitis- virus-vakzine

Country Status (9)

Country Link
US (1) US4118478A (de)
JP (1) JPS51133414A (de)
AT (1) AT349136B (de)
AU (1) AU505999B2 (de)
CA (1) CA1066190A (de)
DE (1) DE2610717C3 (de)
MX (1) MX3473E (de)
NL (1) NL7602621A (de)
SE (1) SE437329B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0177015A3 (en) * 1984-10-02 1988-01-13 New York Blood Center, Inc. Hepatitis b antigenic compositions and vaccines against hepatitis b derived therefrom

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4102996A (en) * 1977-04-20 1978-07-25 Merck & Co., Inc. Method of preparing hepatitis B core antigen
DE2750045A1 (de) * 1977-11-09 1979-05-10 Behringwerke Ag Verfahren zur entfernung von detergentien aus virusantigensuspensionen
ZA792485B (en) * 1978-06-07 1980-06-25 New York Blood Center Inc Vaccine for active immunization containing hepatitis b surface and/or e-antigens
US4181713A (en) * 1978-10-30 1980-01-01 Merck & Co., Inc. Isolation of HBs Ag
US4395395A (en) * 1979-05-21 1983-07-26 The United States Of America As Represented By The Department Of Health And Human Services Detection of non-A, non-B hepatitis associated antigen
JPS5610119A (en) * 1979-07-05 1981-02-02 Alpha Therapeutic Corp Manufacture of b type hepatitis infection preventive vaccine
JPH0625069B2 (ja) * 1981-01-29 1994-04-06 ブリティッシュ・テクノロジー・グループ・リミテッド Ｂ型肝炎ワクチン製造方法
DE3150935A1 (de) * 1981-12-23 1983-06-30 Uwe Dr.med. 3400 Göttingen Böttcher Verfahren zur herstellung eines hepatitis-b impfstoffes
US5324513A (en) * 1984-03-07 1994-06-28 Institut Pasteur Composition useful for the fabrication of vaccines
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
CA3080656A1 (en) 2017-10-30 2019-05-09 Baxalta GmbH Environmentally compatible detergents for inactivation of lipid-enveloped viruses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017360A (en) * 1975-05-14 1977-04-12 Merck & Co., Inc. Method for purifying hepatitis B antigen
US4024243A (en) * 1975-06-16 1977-05-17 Merck & Co., Inc. Process for isolating hepatitis B antigen

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0177015A3 (en) * 1984-10-02 1988-01-13 New York Blood Center, Inc. Hepatitis b antigenic compositions and vaccines against hepatitis b derived therefrom

Also Published As

Publication number Publication date
DE2610717B2 (de) 1980-05-14
MX3473E (es) 1980-12-10
US4118478A (en) 1978-10-03
ATA186276A (de) 1978-08-15
DE2610717C3 (de) 1981-02-05
JPS51133414A (en) 1976-11-19
SE437329B (sv) 1985-02-25
SE7602871L (sv) 1976-09-15
AU505999B2 (en) 1979-12-13
NL7602621A (nl) 1976-09-16
AU1196776A (en) 1977-09-15
CA1066190A (en) 1979-11-13
DE2610717A1 (de) 1977-05-26

Similar Documents

Publication Publication Date Title
AT356569B (de) Verfahren zur herstellung eines frost- bestaendigen betons
ATA427276A (de) Verfahren zur herstellung einer nutsche
ATA843476A (de) Verfahren zur herstellung einer stabilen lyopilisierbaren bzw. lyophilisierten erythro- zyten-praeparation
AT358166B (de) Verfahren zur herstellung einer verbesserten vakzine gegen newcastle-krankheit
AT349136B (de) Verfahren zur herstellung einer hepatitis- virus-vakzine
DD131762A5 (de) Verfahren zur herstellung eines pferde-rhinopneumonievakzins
AT362496B (de) Verfahren zur herstellung einer tollwut-vaccine
ATA449178A (de) Verfahren zur herstellung eines keramischen gegenstandes
AT345450B (de) Verfahren zur herstellung eines neuen lebenden rabiesvirusstammes
AT343286B (de) Verfahren zur herstellung einer topischen zubereitung
AT350181B (de) Verfahren zur herstellung einer mischvaccine
AT334524B (de) Verfahren zur herstellung einer virus-untereinheiten-vaccine
AT358167B (de) Verfahren zur herstellung von fruehsommer- -meningoenzephalitis-virus (fsme-virus)- -vakzinen
AT340583B (de) Verfahren zur herstellung einer katzen-rhinotracheitis-vaccine
AT368390B (de) Verfahren zur herstellung einer heterovakzine
AT344676B (de) Verfahren zur herstellung einer perpropionsaeureloesung
AT351160B (de) Verfahren zur herstellung einer abgeschwaechten influenzavirusvakzine
DD129153A5 (de) Verfahren zur herstellung einer gewuerzmischung
DD138506A1 (de) Verfahren zur herstellung einer waessrigen loesung
ATA274876A (de) Verfahren zur herstellung einer sondennahrung
AT351264B (de) Verfahren zur herstellung einer phenolharzmasse
AT338416B (de) Verfahren zur herstellung einer influenza-b-virus-lebendvaccine
AT362495B (de) Verfahren zur herstellung einer virusvaccine
AT369989B (de) Verfahren zur herstellung einer kombinationsvaccine
DD130910A1 (de) Verfahren zur herstellung einer suessware

Legal Events

Date Code Title Description
EFA Change in the company name
ELJ Ceased due to non-payment of the annual fee